Addressing Hypertension Care in Africa

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 14, 2019

Primary Completion Date

May 3, 2021

Study Completion Date

December 30, 2024

Conditions
HypertensionDiabetesTelemedicine
Interventions
BEHAVIORAL

Enhanced Usual Care Group

"Medtronic® Labs' Akoma pa app, a culturally-tested and locally attuned mobile health platform, will be used in the intervention arm of the study to improve communication between the Community Health Officer (CHO) and the participant. This platform will be used to enhance shared decision making, clinical decision support, participatory communication, knowledge, treatment adherence (medication and lifestyle modification), and self-monitoring of hypertension. We will test the feasibility of the Akoma pa app in addressing patient-level and provider-level barriers to hypertension control.~The app will consist of the following components:~1. Reminders~2. Participant to CHO messaging~3. Home BP tracking~4. Educational materials on cardiovascular disease (CVD) and Stroke- Participants will have access to education modules on reducing the risk of CVD and stroke tailored to their knowledge level.~5. CHO provider portal- The provider portal will include decision support tools."

OTHER

Usual Care Group

Regular/usual appointments or visits to patients' healthcare provider for management of study outcomes

Trial Locations (4)

Unknown

Komfo Anokye Teaching Hospital, Kumasi

Kumasi South Hospital, Kumasi

Manhyia Government Hospital, Kumasi

Suntreso Government Hospital, Kumasi

All Listed Sponsors
collaborator

Johns Hopkins Alliance for a Healthier World

UNKNOWN

lead

Johns Hopkins University

OTHER

NCT04010344 - Addressing Hypertension Care in Africa | Biotech Hunter | Biotech Hunter